In: monoclonal antibody
Check out our new article: ‘Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations’ (Advanced Drug Delivery Reviews – Open Access)
May 23, 2025Publication: Laura Pineiro-Alonso, Inés Rubio-Prego, Alexandra Lobyntseva, Eva González-Freire, Robert Langer, María José Alonso, Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations, Advanced Drug Delivery Reviews, Volume 222, 2025, 115606, ISSN 0169-409X, https://doi.org/10.1016/j.addr.2025.115606
Read More
Check out our new article: ‘Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors’ – OPEN ACCESS
July 19, 2024Ana M. López-Estévez, Lucía Sanjurjo, Ángela Turrero, Iker Arriaga, Nicola G.A. Abrescia, Ana Poveda, Jesús Jiménez-Barbero, Anxo Vidal, Dolores Torres, María José Alonso, Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors, Journal of Controlled Release, Volume 373, 2024, Pages 277-292, ISSN 0168-3659,
https://doi.org/10.1016/j.jconrel.2024.07.032
Check out our new article: ‘Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights’ – OPEN ACCESS
July 12, 2024López-Estévez, A.M., Zhang, Y., Medel, M. et al. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights. Nano Res. (2024). https://doi.org/10.1007/s12274-024-6826-8
Read More